2/2
09:44 am
ardx
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results [Yahoo! Finance]
Low
Report
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results [Yahoo! Finance]
1/29
10:59 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at TD Cowen.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at TD Cowen.
1/29
08:03 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
1/28
07:02 pm
ardx
Is Ardelyx (ARDX) Pricing Reflect Its Strong Multi Year Share Price Performance [Yahoo! Finance]
Low
Report
Is Ardelyx (ARDX) Pricing Reflect Its Strong Multi Year Share Price Performance [Yahoo! Finance]
1/28
12:37 pm
ardx
How Ardelyx's Phase 3 ACCEL Trial for IBSRELA in CIC Will Impact Ardelyx (ARDX) Investors [Yahoo! Finance]
Low
Report
How Ardelyx's Phase 3 ACCEL Trial for IBSRELA in CIC Will Impact Ardelyx (ARDX) Investors [Yahoo! Finance]
1/28
08:29 am
ardx
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
Low
Report
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
1/27
07:19 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
1/26
10:16 am
ardx
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
Low
Report
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
1/23
05:06 am
ardx
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/21
01:05 pm
ardx
Ardelyx: Assessment Of Acquisition Rumors [Seeking Alpha]
Low
Report
Ardelyx: Assessment Of Acquisition Rumors [Seeking Alpha]
1/21
09:05 am
ardx
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Wedbush from $16.00 to $19.00. They now have an "outperform" rating on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Wedbush from $16.00 to $19.00. They now have an "outperform" rating on the stock.
1/20
10:32 am
ardx
Ardelyx gains on report Zydus Lifesciences in talks to purchase [Seeking Alpha]
Low
Report
Ardelyx gains on report Zydus Lifesciences in talks to purchase [Seeking Alpha]
1/20
06:15 am
ardx
Ardelyx: IBSRELA Momentum Drives Opportunity [Seeking Alpha]
Low
Report
Ardelyx: IBSRELA Momentum Drives Opportunity [Seeking Alpha]
1/9
07:03 pm
ardx
Assessing Ardelyx (ARDX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Medium
Report
Assessing Ardelyx (ARDX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
1/9
07:03 pm
ardx
Why The Ardelyx ARDX Story Is Shifting On New Ibsrela Targets And Valuation Assumptions [Yahoo! Finance]
Medium
Report
Why The Ardelyx ARDX Story Is Shifting On New Ibsrela Targets And Valuation Assumptions [Yahoo! Finance]
1/9
08:43 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
1/9
07:18 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Medium
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research.
1/8
05:04 pm
ardx
Ardelyx (NASDAQ:ARDX) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.
Medium
Report
Ardelyx (NASDAQ:ARDX) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.
1/8
02:00 pm
ardx
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/8
08:30 am
ardx
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
High
Report
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
1/5
09:52 am
ardx
Ardelyx (ARDX) Moves 5.5% Higher: Will This Strength Last? [Yahoo! Finance]
Low
Report
Ardelyx (ARDX) Moves 5.5% Higher: Will This Strength Last? [Yahoo! Finance]
1/5
09:04 am
ardx
When Does Changing Course Become Securities Fraud? Court Rules Against Ardelyx Shareholders [Yahoo! Finance]
Low
Report
When Does Changing Course Become Securities Fraud? Court Rules Against Ardelyx Shareholders [Yahoo! Finance]
12/30
07:07 pm
ardx
Ardelyx Insider Ups Holding By 19% During Year [Yahoo! Finance]
Low
Report
Ardelyx Insider Ups Holding By 19% During Year [Yahoo! Finance]
11/27
06:16 pm
ardx
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/25
07:19 am
ardx
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..